InvestorsHub Logo
Followers 15
Posts 1647
Boards Moderated 0
Alias Born 05/15/2015

Re: None

Monday, 04/03/2017 10:55:20 AM

Monday, April 03, 2017 10:55:20 AM

Post# of 23979
GOVX @ .06: $658,000 HIV grant via NIH:

Roughly 20% of market cap.

In addition, Zika grant is also due.

GOVX a low floater (in regard to otcbb).

Imo, the single biggest bang for the buck in bio/pharma right now.


Link:
http://finance.yahoo.com/news/geovax-awarded-658-000-nih-130000118.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.